Explainable time-to-progression predictions in multiple sclerosis.

Journal: Computer methods and programs in biomedicine

Publication Year: 

Authors & Co-authors:  D'hondt Robbe R Dedja Klest K Aerts Sofie S Van Wijmeersch Bart B Kalincik Tomas T Reddel Stephen S Havrdova Eva Kubala EK Lugaresi Alessandra A Weinstock-Guttman Bianca B Mrabet Saloua S

Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Publication Year: 2024

Authors & Co-authors:  Yeh Wei Z WZ Van Der Walt Anneke A Skibina Olga G OG Kalincik Tomas T Alroughani Raed R Kermode Allan G AG Fabis-Pedrini Marzena J MJ Carroll William M WM Lechner-Scott Jeannette J Boz Cavit C

Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Publication Year: 2024

Authors & Co-authors:  Yeh Wei Z WZ Van Der Walt Anneke A Skibina Olga G OG Kalincik Tomas T Alroughani Raed R Kermode Allan G AG Fabis-Pedrini Marzena J MJ Carroll William M WM Lechner-Scott Jeannette J Boz Cavit C

Machine-learning-based prediction of disability progression in multiple sclerosis: An observational, international, multi-center study.

Journal: PLOS digital health

Publication Year: 

Authors & Co-authors:  De Brouwer Edward E Becker Thijs T Werthen-Brabants Lorin L Dewulf Pieter P Iliadis Dimitrios D Dekeyser Cathérine C Laureys Guy G Van Wijmeersch Bart B Popescu Veronica V Dhaene Tom T

Safety and effectiveness of disease-modifying therapies after switching from natalizumab.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Publication Year: 

Authors & Co-authors:  Zeineddine Maya M Al-Roughani Raed R Farouk Ahmed Samar S Khoury Samia S El-Ayoubi Nabil N Al-Mahdawi Akram A Al-Khabouri Jaber J Al-Asmi Abdullah A Chentouf Amina A Inshasi Jihad J

A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic.

Journal: Journal of neurology

Publication Year: 

Authors & Co-authors:  Lal Anoushka P AP Foong Yi Chao YC Sanfilippo Paul G PG Spelman Tim T Rath Louise L Levitz David D Fabis-Pedrini Marzena M Foschi Matteo M Habek Mario M Kalincik Tomas T

Comparative effectiveness in multiple sclerosis: A methodological comparison.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Publication Year: 2023

Authors & Co-authors:  Roos Izanne I Diouf Ibrahima I Sharmin Sifat S Horakova Dana D Havrdova Eva Kubala EK Patti Francesco F Shaygannejad Vahid V Ozakbas Serkan S Izquierdo Guillermo G Eichau Sara S

Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Publication Year: 2023

Authors & Co-authors:  Daruwalla Cyrus C Shaygannejad Vahid V Ozakbas Serkan S Havrdova Eva Kubala EK Horakova Dana D Alroughani Raed R Boz Cavit C Patti Francesco F Onofrj Marco M Lugaresi Alessandra A

The risk of secondary progressive multiple sclerosis is geographically determined but modifiable.

Journal: Brain : a journal of neurology

Publication Year: 2023

Authors & Co-authors:  Sharmin Sifat S Roos Izanne I Simpson-Yap Steve S Malpas Charles C Sánchez Marina M MM Ozakbas Serkan S Horakova Dana D Havrdova Eva K EK Patti Francesco F Alroughani Raed R

Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial.

Journal: Journal of neurology, neurosurgery, and psychiatry

Publication Year: 2023

Authors & Co-authors:  Diouf Ibrahima I Malpas Charles B CB Sharmin Sifat S Roos Izanne I Horakova Dana D Kubala Havrdova Eva E Patti Francesco F Shaygannejad Vahid V Ozakbas Serkan S Eichau Sara S

Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis.

Journal: JAMA neurology

Publication Year: 2023

Authors & Co-authors:  Kalincik Tomas T Sharmin Sifat S Roos Izanne I Freedman Mark S MS Atkins Harold H Burman Joachim J Massey Jennifer J Sutton Ian I Withers Barbara B Macdonell Richard R

Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study.

Journal: Journal of neurology, neurosurgery, and psychiatry

Publication Year: 

Authors & Co-authors:  Dekeyser Cathérine C Hautekeete Matthias M Cambron Melissa M Van Pesch Vincent V Patti Francesco F Kuhle Jens J Khoury Samia S Lechner Scott Jeanette J Gerlach Oliver O Lugaresi Alessandra A